Press release
Warm Autoimmune Hemolytic Anemia Market Size (7MM) was estimated to be ~USD 300 million in 2023, which is expected to grow by 2034, estimates DelveInsight
Warm Autoimmune Hemolytic Anemia Drugs Market
To know in detail about the Warm Autoimmune hemolytic anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here @ Warm Autoimmune hemolytic anemia Market Forecast - https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key takeaways from Warm Autoimmune hemolytic anemia Market Report
• Among the 7MM, the US accounted for the highest prevalent cases of autoimmune hemolytic anemia in 2023, with around 57,000 cases; these cases are expected to increase during the forecast period.
• Among gender-specific prevalent cases of wAIHA, females stand out as major contributors. In 2023, Females accounted for up to 60% cases of wAIHA. These cases are anticipated to increase by 2034 in the US.
• Amongst EU4 and the UK, the total prevalent cases of wAIHA were highest in Germany, while the lowest number of cases were in Spain in 2023.
• According to the estimates, in Japan, it is observed that wAIHA was most prevalent in the =65 year's age group, accounting for over 64% of total cases in 2023.
• The leading Warm Autoimmune hemolytic anemia Companies such as Zenas BioPharma, Novartis, MorphoSys, Alpine Immune Sciences, Rigel Pharma, Incyte Corp, Sanofi, Johnson & Johnson, Janssen Research & Development, Annexon, Inc., Apellis Pharma, Rigel Pharmaceuticals, Hutchison Medipharma Limited, and others
• Promising Warm Autoimmune hemolytic anemia Therapies such as Obexelimab (ZB012), Ianalumab, Povetacicept, Fostamatinib, Parsaclisib, Rilzabrutinib, Nipocalimab, M281, ANX005, APL-2, Fostamatinib disodium, HMPL-523(300mg PO QD), and others
Get a Free sample for the Warm Autoimmune hemolytic anemia Market Report @ https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Warm Autoimmune hemolytic anemia Epidemiology Segmentation:
The Warm Autoimmune hemolytic anemia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Warm Autoimmune hemolytic anemia
• Prevalent Cases of Warm Autoimmune hemolytic anemia by severity
• Gender-specific Prevalence of Warm Autoimmune hemolytic anemia
• Diagnosed Cases of Episodic and Chronic Warm Autoimmune hemolytic anemia
Download the report to understand which factors are driving Warm Autoimmune hemolytic anemia epidemiology trends @ Warm Autoimmune hemolytic anemia Epidemiology Forecast- https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Warm Autoimmune hemolytic anemia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Warm Autoimmune hemolytic anemia market or expected to get launched during the study period. The analysis covers Warm Autoimmune hemolytic anemia market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share. The report also covers the Warm Autoimmune hemolytic anemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Warm Autoimmune hemolytic anemia Therapies and Key Companies
• Obexelimab (ZB012): Zenas BioPharma
• Ianalumab: Novartis/MorphoSys
• Povetacicept: Alpine Immune Sciences
• Fostamatinib: Rigel Pharmaceuticals
• Parsaclisib: Incyte Corporation
• Rilzabrutinib: Sanofi
• Nipocalimab: Johnson & Johnson
• M281: Janssen Research & Development
• ANX005: Annexon, Inc.
• APL-2: Apellis Pharmaceuticals, Inc.
• Fostamatinib disodium: Rigel Pharmaceuticals
• HMPL-523(300mg PO QD): Hutchison Medipharma Limited
Discover more about therapies set to grab major Warm Autoimmune hemolytic anemia market share @ Warm Autoimmune hemolytic anemia Treatment Market- https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Warm Autoimmune hemolytic anemia Market Drivers
• Increasing patient population
• Advancement in research and development
• Improved clinical trials
• Patient assistance programs
• New therapeutic agents
Warm Autoimmune hemolytic anemia Market Barriers
• Increasing refractory cases
• Associated co-morbidities
• Unavailability of better treatment options
• Therapy failure
• Lack of disease understanding
• Unavailability of curative treatment
Scope of the Warm Autoimmune hemolytic anemia Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Key Warm Autoimmune hemolytic anemia Companies: Zenas BioPharma, Novartis, MorphoSys, Alpine Immune Sciences, Rigel Pharma, Incyte Corp, Sanofi, Johnson & Johnson, Janssen Research & Development, Annexon, Inc., Apellis Pharma, Rigel Pharmaceuticals, Hutchison Medipharma Limited, and others
• Key Warm Autoimmune hemolytic anemia Therapies: Obexelimab (ZB012), Ianalumab, Povetacicept, Fostamatinib, Parsaclisib, Rilzabrutinib, Nipocalimab, M281, ANX005, APL-2, Fostamatinib disodium, HMPL-523(300mg PO QD), and others
• Warm Autoimmune hemolytic anemia Therapeutic Assessment: Warm Autoimmune hemolytic anemia current marketed and Warm Autoimmune hemolytic anemia emerging therapies
• Warm Autoimmune hemolytic anemia Market Dynamics: Warm Autoimmune hemolytic anemia market drivers and Warm Autoimmune hemolytic anemia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Warm Autoimmune hemolytic anemia Unmet Needs, KOL's views, Analyst's views, Warm Autoimmune hemolytic anemia Market Access and Reimbursement
To know more about Warm Autoimmune hemolytic anemia companies working in the treatment market, visit @ Warm Autoimmune hemolytic anemia Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Warm Autoimmune hemolytic anemia Market Report Introduction
2. Executive Summary for Warm Autoimmune hemolytic anemia
3. SWOT analysis of Warm Autoimmune hemolytic anemia
4. Warm Autoimmune hemolytic anemia Patient Share (%) Overview at a Glance
5. Warm Autoimmune hemolytic anemia Market Overview at a Glance
6. Warm Autoimmune hemolytic anemia Disease Background and Overview
7. Warm Autoimmune hemolytic anemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Warm Autoimmune hemolytic anemia
9. Warm Autoimmune hemolytic anemia Current Treatment and Medical Practices
10. Warm Autoimmune hemolytic anemia Unmet Needs
11. Warm Autoimmune hemolytic anemia Emerging Therapies
12. Warm Autoimmune hemolytic anemia Market Outlook
13. Country-Wise Warm Autoimmune hemolytic anemia Market Analysis (2020-2034)
14. Warm Autoimmune hemolytic anemia Market Access and Reimbursement of Therapies
15. Warm Autoimmune hemolytic anemia Market Drivers
16. Warm Autoimmune hemolytic anemia Market Barriers
17. Warm Autoimmune hemolytic anemia Appendix
18. Warm Autoimmune hemolytic anemia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Warm Autoimmune Hemolytic Anemia Market Size (7MM) was estimated to be ~USD 300 million in 2023, which is expected to grow by 2034, estimates DelveInsight here
News-ID: 4311919 • Views: …
More Releases from DelveInsight Business Research LLP
Cervical Cancer Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Inn …
DelveInsight's, "Cervical Cancer Pipeline Insights 2025" report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Cervical Cancer pipeline landscape. It covers the Cervical Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cervical Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download DelveInsight's comprehensive Cervical Cancer Pipeline Report…
Helicobacter Pylori Infection Market Size (7MM) was ~USD 2,672.5 million in 2022 …
(Albany, USA) DelveInsight's report, "Helicobacter Pylori Infections Market Insights, Epidemiology, and Market Forecast - 2034," delivers an in-depth analysis of the H. pylori infection market across the United States, EU5, and Japan. The study includes historical and forecasted epidemiology, current and emerging treatment patterns, market size projections from 2020-2034, and detailed drug-level market share assessments. Additionally, the report evaluates treatment pathways, major market drivers, limitations, and areas of unmet clinical…
Human papillomavirus Associated Cancer Clinical Trial Pipeline Expands as 50+ Co …
DelveInsight's, "Human papillomavirus (HPV) Associated Cancer Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Human papillomavirus (HPV) Associated Cancer pipeline landscape. It covers the Human papillomavirus (HPV) Associated Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Human papillomavirus (HPV) Associated Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights…
Alcohol Use Disorder Pipeline 2025: Pioneering Clinical Developments by 30+ Glob …
With alcohol use disorder (AUD) reaching epidemic levels worldwide and contributing to comorbidities such as diabetes, cardiovascular disease, and certain cancers, there is an increasing need for safer and more effective treatments. DelveInsight reports that over 30 pharmaceutical and biotech companies are actively developing more than 30 therapeutic candidates targeting AUD. These therapies are in various stages of clinical and preclinical development, reflecting significant innovation and a strong commitment to…
More Releases for Warm
Chinese cinnamon: A fragrant and warm guardian
Cinnamon, a spice and medicinal herb originating from ancient China, has earned the reputation of "King of Fragrances" for its unique aroma and rich medicinal value since ancient times. In traditional Chinese culture, cinnamon [https://www.ruiqiaofoods.com/dried-cinnamon-100-natural-healthy-spice-product/] not only symbolizes auspiciousness, happiness, and warmth, but also has become an indispensable part of people's lives with its profound cultural heritage and practical value.
Cinnamon, also known as cinnamon or official cinnamon, is the dried…
How Big is Warm Water Aquaculture Feed Market?
In 2022, the Global Warm Water Aquaculture Feed Market achieved a value of US$ 4.41 billion. It is projected to escalate to US$ 5.96 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 3.85% during the forecast period from 2023 to 2030.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Warm Water Aquaculture Feed market has been growing significantly…
Warm Autoimmune Hemolytic Anemia (WAIHA) Market
The Global Warm Autoimmune Hemolytic Anemia (WAIHA) Market is projected to exhibit a high CAGR during the forecast period of 2023-2030. WAIHA, which accounts for 60-70% of autoimmune hemolytic anemia (AIHA) cases, is primarily caused by autoantibodies targeting immunoglobulin G (IgG), leading to red blood cell destruction.
Market Dynamics:
Diagnostic Advancements:
Enhanced Laboratory Techniques: Developments in diagnostic laboratory methods, such as flow cytometry and serologic assays, have improved the accuracy and timeliness of…
Warm Slippers Market | Bearpaw, Dearfoams, Hender Scheme, HomeIdeas
Introduction:
The introduction to the report serves as a gateway into the comprehensive world of the warm slippers market. As industries continue to evolve and adapt to changing consumer demands and technological advancements, understanding the market dynamics becomes paramount for industry stakeholders. The report takes on the responsibility of offering a profound and all-encompassing analysis of the warm slippers market, catering to the needs of a diverse audience that includes manufacturers,…
Spring Into Warm Weather With Olive Juice
Children’s Clothing Company Carries Message Of Fun-In-The-Sun
Philadelphia, PA (May 3, 2011) – With spring officially here, the only thing heating up more than the temperature is the fun and fresh looks from children’s apparel line, Olive Juice. From Easter to Memorial Day Weekend, and even Fourth of July, these coming months are all about capturing the fleeting moments of childhood and making lasting memories. Olive Juice has created adorable,…
Kerala Beaches are Warm, Inviting and Sensuous
Kerala the land where nature utters its glory through pristine backwaters, palm fringed beaches, tranquil villages and greenery in profusion. The National Geographic Traveler Magazine named Kerala as one of the ‘Ten Paradises of the World’ and ‘Fifty Places of a Lifetime’. This categorization heightens the glory of Kerala across the globe and make it a hotspot for spending a memorable holidays.
Several mesmerizing destinations of Kerala promise the best…
